According to a new analysis in JAMA Cardiology, the high price of SGLT2 inhibitors such as dapagliflozin and empagliflozin is limiting their value in patient care. Purchasing Farxiga or Jardiance from US pharmacies is estimated to cost approximately $8000 per annum. From IsraelPharm, the cost is close to just $1000.